Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2007 2
2008 2
2009 2
2011 1
2013 1
2014 2
2015 3
2016 1
2021 2
2023 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021.
Martínez-Baz I, Miqueleiz A, Casado I, Navascués A, Trobajo-Sanmartín C, Burgui C, Guevara M, Ezpeleta C, Castilla J; Working Group for the Study of COVID-19 in Navarra. Martínez-Baz I, et al. Euro Surveill. 2021 May;26(21):2100438. doi: 10.2807/1560-7917.ES.2021.26.21.2100438. Euro Surveill. 2021. PMID: 34047271 Free PMC article.
Cause of death in hospitalized patients with laboratory-confirmed influenza.
Casado I, Martínez-Baz I, Floristán Y, Chamorro J, Ezpeleta C, Castilla J; Network for Influenza Surveillance in Hospitals of Navarra. Casado I, et al. An Sist Sanit Navar. 2015 May-Aug;38(2):263-8. doi: 10.23938/ASSN.0075. An Sist Sanit Navar. 2015. PMID: 26486532 Free article.
Product-specific COVID-19 vaccine effectiveness against secondary infection in close contacts, Navarre, Spain, April to August 2021.
Martínez-Baz I, Trobajo-Sanmartín C, Miqueleiz A, Guevara M, Fernández-Huerta M, Burgui C, Casado I, Portillo ME, Navascués A, Ezpeleta C, Castilla J; Working Group for the Study of COVID-19 in Navarre; Investigators, other members of the Working Group for the Study of COVID-19 in Navarre. Martínez-Baz I, et al. Euro Surveill. 2021 Sep;26(39):2100894. doi: 10.2807/1560-7917.ES.2021.26.39.2100894. Euro Surveill. 2021. PMID: 34596016 Free PMC article.
Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis.
Castilla J, Martínez-Baz I, Navascués A, Fernandez-Alonso M, Reina G, Guevara M, Chamorro J, Ortega MT, Albéniz E, Pozo F, Ezpeleta C; Primary Health Care Sentinel Network; Network for Influenza Surveillance in Hospitals of Navarre. Castilla J, et al. Euro Surveill. 2014 Feb 13;19(6):20700. doi: 10.2807/1560-7917.es2014.19.6.20700. Euro Surveill. 2014. PMID: 24556347 Free article.
Risk reduction of hospitalisation and severe disease in vaccinated COVID-19 cases during the SARS-CoV-2 variant Omicron BA.1-predominant period, Navarre, Spain, January to March 2022.
Martínez-Baz I, Trobajo-Sanmartín C, Miqueleiz A, Casado I, Navascués A, Burgui C, Ezpeleta C, Castilla J, Guevara M; Working Group for the Study of COVID-19 in Navarra; Members of the Working Group for the Study of COVID-19 in Navarra. Martínez-Baz I, et al. Euro Surveill. 2023 Feb;28(5):2200337. doi: 10.2807/1560-7917.ES.2023.28.5.2200337. Euro Surveill. 2023. PMID: 36729113 Free PMC article.
A large Legionnaires' disease outbreak in Pamplona, Spain: early detection, rapid control and no case fatality.
Castilla J, Barricarte A, Aldaz J, García Cenoz M, Ferrer T, Pelaz C, Pineda S, Baladrón B, Martín I, Goñi B, Aratajo P, Chamorro J, Lameiro F, Torroba L, Dorronsoro I, Martínez-Artola V, Esparza MJ, Gastaminza MA, Fraile P, Aldaz P. Castilla J, et al. Among authors: lameiro f. Epidemiol Infect. 2008 Jun;136(6):823-32. doi: 10.1017/S0950268807009077. Epub 2007 Jul 30. Epidemiol Infect. 2008. PMID: 17662166 Free PMC article.
Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12.
Castilla J, Martínez-Baz I, Martínez-Artola V, Reina G, Pozo F, García Cenoz M, Guevara M, Morán J, Irisarri F, Arriazu M, Albéniz E, Ezpeleta C, Barricarte A; Primary Health Care Sentinel Network; Network for Influenza Surveillance in Hospitals of Navarre. Castilla J, et al. Euro Surveill. 2013 Jan 31;18(5):20388. doi: 10.2807/ese.18.05.20388-en. Euro Surveill. 2013. PMID: 23399423 Free article.
Direct, indirect and total effects of 13-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in children in Navarra, Spain, 2001 to 2014: cohort and case-control study.
Guevara M, Barricarte A, Torroba L, Herranz M, Gil-Setas A, Gil F, Bernaola E, Ezpeleta C, Castilla J; Working Group for Surveillance of the Pneumococcal Invasive Disease in Navarra. Guevara M, et al. Euro Surveill. 2016;21(14). doi: 10.2807/1560-7917.ES.2016.21.14.30186. Euro Surveill. 2016. PMID: 27103428 Free article.
Reduced incidence of invasive pneumococcal disease after introduction of the 13-valent conjugate vaccine in Navarre, Spain, 2001-2013.
Guevara M, Ezpeleta C, Gil-Setas A, Torroba L, Beristain X, Aguinaga A, García-Irure JJ, Navascués A, García-Cenoz M, Castilla J; Working Group for Surveillance of the Pneumococcal Disease in Navarre. Guevara M, et al. Vaccine. 2014 May 7;32(22):2553-62. doi: 10.1016/j.vaccine.2014.03.054. Epub 2014 Mar 25. Vaccine. 2014. PMID: 24674661
17 results